Commands a peer premium multiple, but this multiple is justified by a strong intrinsic cash flow value.
Moderate quality score of 57/100, reflecting stable operating margins and manageable leverage.
Wall Street forecasts a balanced outlook with consensus price targets near the current price.
Verdict: Average quality business weighed down by significant solvency concerns.
Wall Street sentiment is generally neutral with steady expected earnings growth. This outlook is strongly supported by highly attractive capital returns, anchored by a strong dividend yield, though free cash flow coverage appears tight.
MFAN demonstrates strong business quality with robust profitability and healthy margins. However, this is severely offset by a highly leveraged balance sheet (Debt/EBITDA > 4.0x) and elevated financial risk.
The company maintains stable top-line performance paired with stable bottom-line earnings. This growth is supported by elite operational efficiency, sustaining an impressive 37.7% operating margin.
| Financial Metric | Trend (12Q) | Latest Qtr | 1Y Growth | 3Y CAGR | 5Y CAGR | 10Y CAGR |
|---|---|---|---|---|---|---|
| Revenue | $229.4M | +213.0% | — | — | +9.4% | |
| EBITDA | $135.0M | — | — | — | — | |
| Net Income | -$984K | +48.2% | — | — | -5.6% | |
| EPS (Diluted) | $-0.01 | +104.9% | — | — | -6.2% | |
| Free Cash Flow | $71.1M | -61.9% | -40.7% | +17.9% | — |
| Metric | TTM | 3Y Avg | 5Y Avg | 10Y Avg |
|---|---|---|---|---|
| Gross Margin | 61.6% | 89.7% | 104.3% | 94.3% |
| Operating Margin | 37.7% | 49.4% | 115.4% | 97.1% |
| Net Margin | 18.8% | 32.4% | 107.4% | 100.7% |
| FCF Margin | 22.6% | 42.2% | -76.4% | -22.6% |
| Quarter | EPS Est. | EPS Act. | Surprise | EPS | Rev |
|---|---|---|---|---|---|
| Q2'26Latest | $0.31 | $-0.01 | -103.1% | ||
| Q1'26 | $0.27 | $0.27 | +0.5% | ||
| Q4'25 | $0.27 | $0.46 | +66.4% | ||
| Q3'25 | $0.30 | $0.31 | +6.1% | ||
| Q2'25 | $0.32 | $0.39 | +21.9% |
Total return is +9.8% (1Y), lagging the benchmark by -11.1%
| Period | Total Return | vs S&P 500 (Alpha) | Dividend Contribution |
|---|---|---|---|
| YTD | +4.1% | -3.3% | — |
| 1Y | +9.8% | -11.1% | +8.9% |
| 3YCAGR | +6.4% | -12.9% | +20.6% |
| 5YCAGR | +3.8% | -7.7% | +20.6% |
| 10YCAGR | +1.9% | -11.8% | — |
The S&P 500 is at 30.6x trailing P/E — Expensive relative to historical averages.
Quick answers to common questions about MFA Financial, Inc. 8.875% Senior Notes (MFAN) valuation, health, and returns.
MFA Financial, Inc. 8.875% Senior Notes is estimated to be undervalued under our discounted cash flow framework. relative multiples indicate the stock is Expensive versus peers compared to industry peers. undervalued (implying +140.6% upside to DCF intrinsic value of $60.62)
MFA Financial, Inc. 8.875% Senior Notes has multiple valuation anchors: DCF Intrinsic Value: $60.62 | Peer Relative Fair Value: $18.31. A convergence of these signals offers higher conviction.
MFA Financial, Inc. 8.875% Senior Notes displays fair financial health with a composite quality score of 57/100, supported by a Piotroski F-Score of 5/9, Return on Invested Capital (ROIC) of 4.4%.
MFA Financial, Inc. 8.875% Senior Notes pays a 7.1% dividend yield, covered by a 107% payout ratio with 2 years of growth, supplemented by a 0.6% buyback yield.
MFA Financial, Inc. 8.875% Senior Notes's current growth trajectory is Stable. The company achieved +213.0% 1Y revenue growth and +104.9% 1Y EPS growth, compared to its 3Y revenue CAGR of N/A.
Wall Street consensus is Hold based on 0 analysts, beating EPS expectations in 80% of recent quarters with a -1-quarter streak. The consensus price target represents a N/A change from current levels.
Investment risks for MFA Financial, Inc. 8.875% Senior Notes include: -66.3% 1-year max drawdown, stretched payout ratio. Volatility risk is characterized by a beta of 0.54x.
No. These computations are purely quantitative model outputs for informational purposes. They do not account for qualitative management shifts or macro events. Always consult a licensed RIA before buying or selling shares.
Disclaimer: This page is for informational purposes only and does not constitute financial advice. All valuation models, scores, and target estimates are automated computations under stated assumptions and should not be relied upon as the sole basis for any investment decision.